secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2025-06-02T23:59:59+00:00
Accession:  0001171843-25-003574
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience appoints John Duke to board; incentive share pool increases 3.9M
--------------------------------------------------------------------------------

- John Duke appointed to board effective June 2, 2025; will serve on audit and nominating committees.
- Thomas Loewald resigned from board effective May 30, 2025; no disagreement cited.
- Katherine Eade named Lead Independent Director.
- Shareholders approved Amended and Restated 2021 Incentive Plan, increasing authorized shares by 3,923,000.
- Non-binding advisory vote on executive compensation passed with 23.8M for vs 2.5M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325003574/0001171843-25-003574-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325003574/f8k_060225.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-003574

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer